Jinglai Hao
288 Fute Zhong Road
Shanghai, 200131, China
Shanghai, 200131, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Discovery of novel pan-genotypic HCV NS5A inhibitors containing a novel tetracyclic core.
Journal: Bioorganic & medicinal chemistry letters
Published: December 08, 2018
Discovery of MK-6169, a Potent Pan-Genotype Hepatitis C Virus NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Substitutions.
Journal: Journal of medicinal chemistry
Published: April 24, 2018
Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms.
Journal: Journal of medicinal chemistry
Published: November 04, 2016
Discovery of Chromane Containing Hepatitis C Virus (HCV) NS5A Inhibitors with Improved Potency against Resistance-Associated Variants.
Journal: Journal of medicinal chemistry
Published: October 30, 2016
Structure-activity relationships of proline modifications around the tetracyclic-indole class of NS5A inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: August 15, 2016
Substituted tetracyclic indole core derivatives of HCV NS5A inhibitor MK-8742.
Journal: Bioorganic & medicinal chemistry letters
Published: June 08, 2016
Aryl or heteroaryl substituted aminal derivatives of HCV NS5A inhibitor MK-8742.
Journal: Bioorganic & medicinal chemistry letters
Published: May 17, 2016
Alkyl substituted aminal derivatives of HCV NS5A inhibitor MK-8742.
Journal: Bioorganic & medicinal chemistry letters
Published: April 25, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026